Systemic sclerosis is an autoimmune connective tissue disease, which is characterised by
immune dysregulation and progressive fibrosis that typically affects the skin, with variable …

This expert group consensus statement emphasises the need for standardising the definition
of progressive fibrosing interstitial lung diseases (F-ILDs), with an accurate initial diagnosis …

Background Systemic sclerosis-associated interstitial lung disease (ILD) carries a high
mortality risk; expert guidance is required to aid early recognition and treatment. We aimed …

Abstract Background Systemic sclerosis (SSc) is a rare connective tissue disease with a
heterogeneous clinical course. Interstitial lung disease (ILD) is a common manifestation of …

Objective To assess the safety and efficacy of rituximab in systemic sclerosis (SSc) in clinical
practice. Methods We performed a prospective study including patients with SSc from the …

Fibrotic interstitial lung diseases (ILDs) are often challenging to diagnose and classify, but
an accurate diagnosis has significant implications for both treatment and prognosis. A …

Background Some coronavirus disease 2019 (COVID-19) survivors experience prolonged
and varying symptoms, a condition termed post-acute COVID-19 syndrome (PACS) …

Imaging techniques are an essential component of the diagnostic process for interstitial lung
diseases (ILDs). Chest radiography is frequently the initial indicator of an ILD, and …

Rationale: Previous studies have suggested that interstitial lung disease (ILD) progresses
most rapidly early in the course of systemic sclerosis–associated (SSc)-ILD, and that SSc …

Abstract Introduction Connective Tissue Diseases (CTDs) are systemic autoimmune
conditions characterized by frequent lung involvement. This usually takes the form of …